Compounds > ranitidine
Page last updated: 2024-08-16

ranitidine and Anticipatory Vomiting

ranitidine has been researched along with Anticipatory Vomiting in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Inoue, K; Kai, T; Koh, J; Mihara, H; Mochizuki, H; Okubo, K; Saito, T; Sato, K; Tabei, T1
Hirano, M; Kikkawa, H; Kikuchi, T; Murakami, N; Nozawa, H; Okuda, T; Oya, J; Uno, Y1

Trials

2 trial(s) available for ranitidine and Anticipatory Vomiting

ArticleYear
Multicenter phase II trial of weekly paclitaxel for advanced or metastatic breast cancer: the Saitama Breast Cancer Clinical Study Group (SBCCSG-01).
    Japanese journal of clinical oncology, 2003, Volume: 33, Issue:8

    Topics: Adult; Aged; Alopecia; Antiemetics; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Dexamethasone; Diphenhydramine; Drug Administration Schedule; Feasibility Studies; Female; Humans; Infusions, Intravenous; Lung Neoplasms; Middle Aged; Neutropenia; Paclitaxel; Ranitidine; Soft Tissue Neoplasms; Vomiting, Anticipatory

2003
[Weekly administration of low-dose paclitaxel for advanced or metastatic breast cancer].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2002, Volume: 29, Issue:2

    Topics: Aged; Alopecia; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Dexamethasone; Diphenhydramine; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Infusions, Intravenous; Middle Aged; Nausea; Neoplasm Recurrence, Local; Paclitaxel; Ranitidine; Vomiting, Anticipatory

2002